We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Chemring Group Plc | LSE:CHG | London | Ordinary Share | GB00B45C9X44 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-2.50 | -0.66% | 375.00 | 376.00 | 377.00 | 385.00 | 376.00 | 379.50 | 531,364 | 16:35:21 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Aircraft Parts, Aux Eq, Nec | 481.9M | 5.4M | 0.0195 | 192.82 | 1.04B |
Date | Subject | Author | Discuss |
---|---|---|---|
08/6/2022 08:34 | Except maybe for 'Roke' which is mentioned here & there throughout as a new money-making effort ? | dogwalker | |
08/6/2022 08:18 | Not the great outlook statement I was expecting | dartboard1 | |
04/5/2022 16:33 | Re-rate continues! I imagine each and every EU country is banging Roke’s door down to upgrade and expand Electronic warfare and surveillance which are key for 21st century defence. IMO, Chemring will not end the year independent. | rimau1 | |
06/3/2022 14:09 | Tipped in Mail on Sunday, fwiw. | microscope | |
03/3/2022 10:58 | Salpara - i added on the bell this morning despite being over 30% up on my long term holding. Everything about the AGM statement excited me. Hope you didn’t sell. | rimau1 | |
03/3/2022 08:33 | Didn't see anything to excite but solid statement. I'm now up about 15% and tempted to take my money off the table. | salpara111 | |
03/3/2022 07:47 | Yes, the Sweden order is encouraging. Expecting more like this from NATO / euro countries over the next 12 months | dartboard1 | |
03/3/2022 07:33 | Fantastic AGM statement. 1. Supply constraints continue to be effectively managed. 2. Trading at top end of consensus 3. Roke and the EW segment are seeing particularly strong demand in 2022 with a significant order from Sweden (which i think is a new customer?). Trading around 15x current earnings Chemring should have a record year ahead IMO. | rimau1 | |
03/3/2022 07:32 | Slightly ahead of analyst expectations ... solid and steady | dartboard1 | |
02/3/2022 07:22 | Due on Thursday actually | redwing1 | |
28/2/2022 13:06 | Trading statement due Wednesday | rimau1 | |
28/2/2022 12:34 | Gotta be some contracts for chemring in the 100 billion Germany are spending !! | dartboard1 | |
28/2/2022 10:55 | Re-rate has only just started. Roke has best in place reputation in cyber defence, my long standing view is unchanged that we will get swallowed by a much bigger US fish. I added all the way down to the 260’s and even added this morning. Also adding over at QQ which is even better value. | rimau1 | |
28/2/2022 09:03 | Stunning news from Germany, finally committing to meet the 2% GDP defence spending required by NATO, an additional 100 Billion spend! Who would have thought that it would be Putin who would unite the West and lead to dramatic increases in military spending. | salpara111 | |
28/2/2022 08:31 | Bought here this morning. Chart looking v good imo. | scottishfield | |
24/2/2022 08:05 | How does this go down on a day like today? | dartboard1 | |
14/2/2022 17:48 | ...a bit dated... For more than 100 years, Chemring is an innovative solutions supplier for the aerospace, defence and security sectors. The company operates in over 50 countries, working with military, agencies, and businesses, with the ambition of making the world a safer and better place. CHG provides sensors, electronic systems, technology solutions, countermeasures, and other services. The issue here is history. After prosperous years during the Gulf War it went through 10 tough years marked by bad debt-fuelled acquisition spree destroying the financial position. However. The company turned towards its shareholders, sold off operations and adopted a whole new strategy. Moreover, they have a golden fish under their umbrella in the face of Roke - the cyber security arm. Roke is generating £80m of turnover, compare that to the good assets in the sector EV/Sales average ratio of 5, means it could potentially be half of Chemring’s value, or even more. The prospects of it are also very good as it works with the UK Government and a solid entrance in the big game of US, with contract signed last year. Half year trading update presented company’s progress in recent years with performance ahead of expectations. Strong cash conversion and EBITDA 10% above last year interim results show improving quality of earnings. Cash flow was negative for the interim, driven by retirement of debt, which was not outbalanced by the significant decrease in CapEx. This trend in CapEx is expected to reverse as we go through H2. The boost in DPS of 23% is expected to decrease medium-term earning cover. Consensus for FY21 is revised upwards, based on the good performance in H1 and a strong order book of £450m at the end of April....from WealthOracleAM | km18 | |
14/12/2021 07:22 | From initial read the results look good despite an FX headwind. Margins are also up across the divisions whilst competitors talk of labour shortages, input cost inflation and supply constraints. Compare this to Cohorts profits warning this morning! High quality long term buy at these levels IMO and i continue to add below £3 on general market down days. 18x forward earnings (high quality sticky growing order book) and a growing dividend means this won’t stay independent IMO. | rimau1 | |
10/12/2021 09:00 | Full Year results on Tuesday, looking forward to a nice positive outlook statement. End markets remain strong with Australia beefing up spending for the China threat and Nato and under pressure from Russia. I don’t expect Chemring to remain independent for long as a high quality niche operator. | rimau1 | |
02/11/2021 07:29 | A positive RNS this morning. | dogwalker | |
27/10/2021 21:30 | free stock charts from uk.advfn.com free stock charts from uk.advfn.com | buywell3 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions